Thunder Bay, ON
ZEN Graphene Solutions Ltd. (“ZEN” or “Company”) (TSXV: ZEN) announces that its winter drilling program on the Albany Graphite Project has concluded with two large diameter holes totalling 263 metres having been completed. These two holes yielded over 110 tonnes of Albany Graphite material, sufficient material to produce several tonnes of purified graphite to be used as pre-cursor graphene material for graphene applications testing. The recovered material will now be prepared for shipping so that it can be processed into high purity graphite for graphene production.
Dr. Francis Dubé, Zenyatta’s Co‐CEO and Head of Business Development and Technology said: “While unseasonably mild temperatures forced earlier termination of the program than originally planned, sufficient material was collected to be used to develop ZEN’s commercialized graphene production process and larger scale graphene applications development. Since the permits remain valid until at least 2022, ZEN will be able to collect additional bulk sample material as needed next year.”
A decision will be made on an additional bulk sampling program during the course of the year as the Company moves forward in developing graphene enhanced applications. Surplus funds from the 2019 program will be re-deployed for other planned activities in 2019 including, environmental baseline, geotechnical and hydrogeological studies.
Mr. Peter Wood, P.Eng, P.Geo., President and COO of ZEN Graphene Solutions, is the “Qualified Person” for the purposes of National Instrument 43-101 and has reviewed, prepared and supervised the preparation of the technical information contained in this news release.
About ZEN Graphene Solutions Ltd.
ZEN Graphene Solutions Ltd. is an emerging graphene technology solutions company with a focus on development of the unique Albany Graphite Project as a precursor graphene material product opportunity and product market development. The Albany Graphite Project provides the company with a competitive advantage in the potential graphene market as independent labs in Japan, UK, Israel, USA and Canada have demonstrated that ZEN’s Albany Graphite/Naturally PureTM easily converts (exfoliates) to graphene, using a variety of simple mechanical and chemical methods.
For further information:
Francis Dubé, Co-Chief Executive Officer
Tel: +1 (289) 821-2820
Email: drfdube@zengraphene.com
To find out more on ZEN Graphene Solutions Ltd., please visit our website at www.ZENGraphene.com . A copy of this news release and all material documents in respect of the Company may be obtained on ZEN’s SEDAR profile at www.sedar.ca.
Forward Looking Statements
This press release contains forward-looking statements. This news release includes certain “forward-looking statements”, which often, but not always, can be identified by the use of words such as “potential”, “believes”, “anticipates”, “expects”, “estimates”, “may”, “could”, “would”, “will”, or “plan”. These statements are based on information currently available to ZEN and ZEN provides no assurance that actual results will meet management’s expectations. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although ZEN believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. ZEN disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. The Company’s full disclosure can be found at https://www.zengraphene.com/di...
About Zentek Ltd.
Zentek is a graphene technology company focused on the research, development, and commercialization of graphene-based novel products to give our commercial partners a competitive advantage by making their products better, safer and greener.
Zentek’s patented ZenGUARD™ coating is shown to have 99% antimicrobial activity and significantly increase the bacterial and viral filtration efficiency for surgical masks and aims to do the same for HVAC filters. Zentek's ZenGUARD™ production facility is located in Guelph, Ontario.
Our second technology platform is ZenARMOR™, which is patent-pending and focused on corrosion protection applications
To find out more about Zentek Ltd., please visit our website at www.zentek.com. A copy of this news release and all material documents in respect of the Company may be obtained on Zentek's SEDAR profile at www.sedar.com.
Forward-Looking Statements
This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.